CN103610850A - Medicine for treating hyperlipemia - Google Patents
Medicine for treating hyperlipemia Download PDFInfo
- Publication number
- CN103610850A CN103610850A CN201310583244.2A CN201310583244A CN103610850A CN 103610850 A CN103610850 A CN 103610850A CN 201310583244 A CN201310583244 A CN 201310583244A CN 103610850 A CN103610850 A CN 103610850A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- blood
- treating hyperlipemia
- hyperlipemia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating hyperlipemia, which is prepared from the following raw materials in parts by weight: 10-20 parts of rhizoma alismatis, 10-15 parts of rhizoma atractylodis macrocephalae, 4-8 parts of raw rhubarb, 10-20 parts of prepared fleece-flower root and 25-35 parts of cassia seed. By selecting the 5 natural traditional Chinese medicines, the medicine for treating hyperlipemia performs the functions of removing pathogenic heat from blood purging intense heat and detoxicating, lowering the blood fat, blood pressure and blood sugar, strengthening the spleen, nourishing the liver, clearing the intestine accumulation and promoting metabolism under the synergetic effects of the active pharmaceutical ingredients, treats both the incidental and fundamental aspects, and has the advantages of favorable effect on treating hyperlipemia and no toxic or side effect. The medicine has the advantages of simple preparation method, low cost and short treatment course and is convenient to take, and the effective rate is up to higher than 98%.
Description
Technical field
The present invention relates to Chinese medicine, specifically a kind of medicine for the treatment of hyperlipemia.
Background technology
Hyperlipemia refers to that blood lipid level is too high, usually feels dizziness, spiritlessness and weakness, insomnia forgetfulness, numb limbs and tense tendons, uncomfortable in chest, cardiopalmus etc.Dyslipidemia person, often with multiple cardiovascular risk factors, can directly cause the disease of some serious harm healths, as atherosclerosis, coronary heart disease, pancreatitis etc.Blood lipid level decline can make the incidence rate of cardiovascular disease and mortality rate reduce along with the decline of serum total cholesterol and LDL-C level.The common medicine of blood fat reducing at present has three types: clofibrate, nicotinic acid class, Statins.Common drug has simvastatin, lovastatin etc.These medicines have certain effect to blood fat reducing, but easily outbreak after drug withdrawal, also period in a medicine want periodic review liver, renal function because these medicines have stimulation to gastrointestinal, Liver and kidney is had to infringement, should not long-term taking.
In order to reduce, to take medicine side effect and affect Liver and kidney, gastrointestinal function, comparatively desirable in clinical practice treatment by Chinese herbs hyperlipemia.
Summary of the invention
The medicine of the treatment hyperlipemia that the object of this invention is to provide a kind of good effect, the course for the treatment of is shorter, cost is low, has no side effect.
The technical scheme that realizes the object of the invention is:
Treating a medicine for hyperlipemia, is to be made by the raw material of following weight proportioning:
Rhizoma Alismatis 10-20 part, Rhizoma Atractylodis Macrocephalae 10-15 part, Radix Et Rhizoma Rhei 4-8 part, Radix Polygoni Multiflori Preparata 10-20 part, Semen Cassiae 25-35 part.
Preferably, the optimum weight proportioning of each raw material is:
15 parts of Rhizoma Alismatis, 12 parts of the Rhizoma Atractylodis Macrocephalaes, 6 parts of Radix Et Rhizoma Rhei, 16 parts of Radix Polygoni Multiflori Preparata, 30 parts of Semen Cassiaes.
Described crude drug wide material sources, price material benefit ， shop of Chinese medicines and market are on sale.
The preparation method of medicine of the present invention, can decoct into decoction according to a conventional method, and concrete grammar is: take by weight ratio each crude drug, add the water of 5-10 times of crude drug total amount, boil rear slow fire boil 10-20 minute with big fire, filter and remove residue, obtains.
Instructions of taking: once a day, each 30 milliliters, generally serveing on 40 days is a course for the treatment of is significant effective fruit after 25 days.
Medicine of the present invention also can be made into pill, powder or capsule.
In the present invention, the effect of each crude drug is as follows:
Rhizoma Alismatis: kidney, spleen are trembled with fear, entered to its sweet in the mouth.Function cures mainly: promoting diuresis to eliminate damp pathogen, treating stranguria, the main dysuria that expels the heat-evil, the puckery pain of pyretic stranguria, edema distension, have loose bowels, dizziness due to fluid-retention, blood fat reducing, blood pressure lowering.
The Rhizoma Atractylodis Macrocephalae: its bitter in the mouth, sweet, warm.Return spleen, stomach warp.There is invigorating the spleen and benefiting QI, dampness diuretic, strengthening superficial resistance to stop perspiration, the effect such as antiabortive.
Radix Polygoni Multiflori Preparata: the Preparation process product that Radix Polygoni Multiflori Preparata is Radix Polygoni Multiflori, bitter in the mouth, sweet, puckery, slightly warm in nature.Return liver, kidney channel.Effect: nourishing the blood and yin, loosening bowel to relieve constipation, dispel the wind, the soreness of the waist and knees of removing toxic substances, blood deficiency Light-headedness, cardiopalmus, insomnia, the hepatic and renal YIN deficiency, early whitening of beard and hair, tinnitus, seminal emission, dryness of the intestine constipation, disease body void, rubella pruritus, carbuncle sore, scrofula, hemorrhoid for a long time.
Radix Et Rhizoma Rhei: the property of medicine is bitter, cold in nature.Return stomach, large intestine, liver, spleen channel.Have and attack the effects such as stagnant, clearing away damp-heat, pathogenic fire purging, removing heat from blood, blood stasis dispelling, removing toxic substances.
Semen Cassiae: bitter in the mouth, sweet and cool in nature.Return liver, kidney, large intestine channel.There is the functions such as clearing away liver-fire, wind-damp dispelling, tonifying kidney and improving eyesight.
The present invention treats the medicine of hyperlipemia and chooses 5 kinds of natural Chinese medicine compatibilities, and each crude drug synergism plays clearing away heat and cooling blood, eliminating fire and detoxication, blood fat reducing, blood pressure lowering, blood sugar lowering, spleen invigorating nourishing the liver, cleanses intestinal long-pending, pushes away the old new effect that causes, treating both the principal and the secondary aspects of a disease at the same time, effective to treatment hyperlipemia, have no side effect.And its preparation method is simple, taking convenience, cost is low, and the course for the treatment of is shorter, and effective percentage reaches more than 98%.
The specific embodiment
Below in conjunction with embodiment, content of the present invention is further described, but is not limitation of the invention.
Embodiment 1:
Treat a medicine for hyperlipemia, the weight proportion of each raw material is:
10 parts of Rhizoma Alismatis, 10 parts of the Rhizoma Atractylodis Macrocephalaes, 4 parts of Radix Et Rhizoma Rhei, 10 parts of Radix Polygoni Multiflori Preparata, 25 parts of Semen Cassiaes.Decoct into according to a conventional method decoction oral.
Embodiment 2:
Treat a medicine for hyperlipemia, the weight proportion of crude drug is:
15 parts of Rhizoma Alismatis, 12 parts of the Rhizoma Atractylodis Macrocephalaes, 6 parts of Radix Et Rhizoma Rhei, 16 parts of Radix Polygoni Multiflori Preparata, 30 parts of Semen Cassiaes.Decoct into according to a conventional method decoction oral.
Embodiment 3:
Treat a medicine for hyperlipemia, the weight proportion of crude drug is:
20 parts of Rhizoma Alismatis, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 8 parts of Radix Et Rhizoma Rhei, 20 parts of Radix Polygoni Multiflori Preparata, 35 parts of Semen Cassiaes.Decoct into according to a conventional method decoction oral.
Experimental example:
In order further to prove the clinical efficacy of medicine of the present invention, select 30 routine patients, the curative effect of medicine of the present invention is carried out to clinical observation.
Efficacy determination be take transference cure as main, and with reference to change situations such as effects, is divided into effective, effective and invalid.
Effective: symptom obviously alleviates and successful improves.
Effective: symptom and effect have certain improvement.
Invalid: symptom and sign are all without improving or DeGrain.
Apply in Drug therapy Hyperlipemia in 30 Cases of the present invention male 22 examples, female's 8 examples.Fundamental symptoms is dizzy, weak, insomnia, uncomfortable in chest, cardiopalmus etc.After oral Drug therapy of the present invention, symptom all has certain improvement, effective 25 examples wherein, effective 30 examples, invalid 0 example, effective percentage 100%.
Claims (2)
1. treat a medicine for hyperlipemia, it is characterized in that being made by the raw material of following weight proportioning: Rhizoma Alismatis 10-20 part, Rhizoma Atractylodis Macrocephalae 10-15 part, Radix Et Rhizoma Rhei 4-8 part, Radix Polygoni Multiflori Preparata 10-20 part, Semen Cassiae 25-35 part.
2. medicine according to claim 1, is characterized in that the weight proportion of each raw material is: 15 parts of Rhizoma Alismatis, 12 parts of the Rhizoma Atractylodis Macrocephalaes, 6 parts of Radix Et Rhizoma Rhei, 16 parts of Radix Polygoni Multiflori Preparata, 30 parts of Semen Cassiaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310583244.2A CN103610850A (en) | 2013-11-20 | 2013-11-20 | Medicine for treating hyperlipemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310583244.2A CN103610850A (en) | 2013-11-20 | 2013-11-20 | Medicine for treating hyperlipemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103610850A true CN103610850A (en) | 2014-03-05 |
Family
ID=50161583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310583244.2A Pending CN103610850A (en) | 2013-11-20 | 2013-11-20 | Medicine for treating hyperlipemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103610850A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103919878A (en) * | 2014-05-04 | 2014-07-16 | 白求恩医科大学制药厂 | Medicine for treating fatty liver and hyperlipidaemia and preparation process thereof |
| CN105381202A (en) * | 2015-11-30 | 2016-03-09 | 山东卫康生物医药科技有限公司 | Composition with blood fat reducing function |
| CN105395827A (en) * | 2015-11-30 | 2016-03-16 | 山东卫康生物医药科技有限公司 | Method for preparing composition with function of reducing blood fat |
| CN103908539B (en) * | 2014-05-03 | 2017-02-01 | 李全浩 | Traditional Chinese medicine composition for treating hypertension as well as preparation method and application of traditional Chinese medicine composition |
| CN109010532A (en) * | 2017-06-10 | 2018-12-18 | 鲍淳 | A kind of drug for treating hyperlipidemia |
| CN109419947A (en) * | 2017-08-29 | 2019-03-05 | 董艳萍 | A kind of drug for treating hyperlipidemia |
-
2013
- 2013-11-20 CN CN201310583244.2A patent/CN103610850A/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| 于俊生等: "《药膳食疗一点通》", 31 May 2012, 青岛出版社 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103908539B (en) * | 2014-05-03 | 2017-02-01 | 李全浩 | Traditional Chinese medicine composition for treating hypertension as well as preparation method and application of traditional Chinese medicine composition |
| CN103919878A (en) * | 2014-05-04 | 2014-07-16 | 白求恩医科大学制药厂 | Medicine for treating fatty liver and hyperlipidaemia and preparation process thereof |
| CN103919878B (en) * | 2014-05-04 | 2016-04-20 | 白求恩医科大学制药厂 | A kind of medicine and preparation technology thereof treating fatty liver and hyperlipemia |
| CN105381202A (en) * | 2015-11-30 | 2016-03-09 | 山东卫康生物医药科技有限公司 | Composition with blood fat reducing function |
| CN105395827A (en) * | 2015-11-30 | 2016-03-16 | 山东卫康生物医药科技有限公司 | Method for preparing composition with function of reducing blood fat |
| CN109010532A (en) * | 2017-06-10 | 2018-12-18 | 鲍淳 | A kind of drug for treating hyperlipidemia |
| CN109419947A (en) * | 2017-08-29 | 2019-03-05 | 董艳萍 | A kind of drug for treating hyperlipidemia |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104367911B (en) | Treat Chinese medicine composition of rheumatism and rheumatoid arthritis and preparation method thereof | |
| CN103610850A (en) | Medicine for treating hyperlipemia | |
| CN103463587A (en) | Traditional Chinese medicine composition for treating deficiency-cold in spleen and stomach | |
| CN103550495B (en) | A kind of Chinese medicine composition of Cure for insomnia | |
| CN104623598A (en) | Traditional Chinese medicine composition for treating deficiency-cold in spleen and stomach | |
| CN103007169B (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN103007190A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN103330826B (en) | Traditional Chinese medicine composition for treating deficiency of lung yin | |
| CN104043087A (en) | Traditional Chinese medicine composition for treating Raynaud syndrome | |
| CN103211962A (en) | Chinese medicinal composition for treating anhypnia | |
| CN103623247A (en) | Medicine for treating dizziness | |
| CN102940820A (en) | Traditional Chinese medicine composition for treating diarrhea | |
| CN104758674A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN104606471A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN104623330A (en) | Chinese medicinal composition for treating hyperlipidemia | |
| CN103800838A (en) | Traditional Chinese medicine composition for treating deficiency of the kidney-yin | |
| CN109010532A (en) | A kind of drug for treating hyperlipidemia | |
| CN103830682A (en) | Traditional Chinese medicine composition for treating liver depression and blood stasis syndromes | |
| CN103816403A (en) | Chinese medicinal composition for treating syndrome of deficiency of liver blood | |
| CN103736027A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN105250671A (en) | Medicine for treating hyperlipoidemia | |
| CN105663850A (en) | Traditional Chinese medicine composition for treating oral ulcer | |
| CN104587275A (en) | Traditional Chinese medicinal composition for treating fire excess from yin deficiency | |
| CN104189656A (en) | Traditional Chinese medicine capsule for treating hyperlipidemia | |
| CN101972335A (en) | Chinese medicinal preparation for treating molluscum contagiosum |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140305 |